Celiac/IBD/Esophageal disorders/Pancreatitis Flashcards
% links between celiac disease and dermatitis herpetiformis ?
> 90% DH pts have CD
up to 25% CD pts have DH
5 ASA in ulcerative colitis : do you give suppository or enema ?
Suppository if up to 18cm disease only
Enema if beyong this but distal to splenic flexure
Achalasia : common sx that are not GI ?
Chest pain
Weight loss
Achalasia : what kind of dysphagia ?
Progressive solid and liquid dysphagia
Regurgitation and reflux sx
Sx refractory to PPI therapy
Achalasia puts you at risk of which cancer ? Do you need surveillance ?
Esophageal squamous cell carcinoma
No routine endoscopic surveillance
Acute GI bleeding with life threatening hemorrhage, what to do with warfarin or DOAC ?
Warfarin : PCC could be considered
DOAC : selective use of PCC or idarucizumab (dabigatran) for those who took DOAC within 24h
Anti LKM in what disease ?
AIH type 2
Anti thrombotic management in elective endoscopy setting : what to do with ASA, DAPT, P2Y12 monotherapy ?
ASA : no interruption
DAPT : interrupte only P2Y12 inhibitor and restart 0-7d post endoscopy
P2Y12 : no consensus
Anti thrombotic management in elective endoscopy setting : what to do with DOACs or warfarin ?
DOACs : interuption and restart 0-7d post endoscopy (no consensus)
Warfarin : no interruption, if interrupted no need to bridge
Aphtous ulcers : crohn or ulcerative colitis ?
Crohn
Are primary sclerosing cholangitis highly symptomatic ?
No up to 50% asx at presentation
Sx include abdo pain, pruritus, fatigue
Autoimmune pancreatitis mimic ?
It can mimic pancreatic cancer, but it responds to steroids
Barrett’s : management if metaplasia with indefinite dysplasia ? dysplasia ?
Indefinite dysplasia : PPI BID, repeat EGD w biopsy in 6 mos
Dyplasia : get expert path review
Barrett’s : management if metaplasia with no dysplasia ?
EGD in 3y if >3cm segment, otherwise in 5years
Barrett’s management if no metaplasia ?
Repeat endo w biopsy in 1-2 y
Barret’s management : what to do if high grade dysplasia or T1a (intramucosal carcinoma)?
- Endoscopic eradication therapy and surveillance in 3,6,12 mo then q1y
Barret’s management : what to do if LOW GRADE DYSPLASIA ?
• Surveillance endoscopy q6mos x 2 then annually
• Endoscopic eradication therapy -> complete eradication -> surveillance endo 1 year then q2y after
Clinical manifestation of proctitis in ulcerative colitis ?
Small volume + frequent BMs w/ blood, tenesmus, urgency, crampy abdo pain
Cobble stone mucosa : Crohn or ulcerative colitis ?
Crohn
Crohn disease : cold stricture ?
Fibrostenotic disease with no active inflammation
Conservative (bowel rest, NG tube), endoscopic dilatation or surgery
Crohn disease : hot stricture what tx ?
Steroid bridge to maintenance tx (biologics)
Crohn disease : tx if fistulas ?
Biologics : infliximab with most evidence then vedolizumab
Anti TNF to induce and maintain
Characterize with EUS or MRI
Crohn disease: what tx if perianal disease ?
Anti TNF +/- ATB PRN
Crohn’s treatment options for moderate to severe ? Induction and maintenance ?
Induction
- Budesonide, pred
- MTX
- Biologics
Anti TNF: infliximab, adalimumab
Anti integrin: vedolizumab
Anti IL12/23): ustekinumab
Maintenance :
- MTX
- Thiopurines (AZP, 6 MP)
- Biologics
WHEN STARTING ANTI TNF : combine with thiopurine (SONIC trial)